» Articles » PMID: 10457027

Are All Helicobacters Equal? Mechanisms of Gastroduodenal Pathology and Their Clinical Implications

Overview
Journal Gut
Specialty Gastroenterology
Date 1999 Aug 24
PMID 10457027
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Most cases of peptic ulcer disease, gastric mucosa associated lymphoid tissue (MALT) lymphoma and cancer of the distal stomach are complications of Helicobacter pylori infection. However, as with most infections not all patients who contract the infection develop the complications of the disease. The other factors that influence the likelihood of problems arising are the virulence of the infecting organism, the genetic constitution and age of the host, and environmental factors. This paper focuses mainly upon the effect of strain differences and the causation of serious disease. There is considerable genetic variation between the different strains of H pylori, some causing a more severe inflammatory response in the host than others. These strains are also associated with a greater likelihood of causing peptic ulcer, atrophic gastritis and intestinal metaplasia and gastric cancer. There is some evidence to suggest that these more virulent organisms may also protect the host from the development of reflux oesophagitis and possibly cancer in the region of the gastro-oesophageal junction. The major difference between virulent and relatively avirulent organisms depends upon the presence of the cag pathogenicity island, a segment of DNA that has been acquired possibly from another organism and is now incorporated within the helicobacter genome. Its presence is associated with the secretion of the vacuolating toxin which is a protein known to cause damage in cell culture and in vivo. As CagA, one of the proteins produced by the pathogenicity island, is highly antigenic, people infected with more virulent strains can be identified by a blood test. Currently controversy surrounds the question as to whether all patients with H pylori should be treated for infection or whether medication should be reserved for those who already have the complications of the infection, or individuals infected with the more virulent strain of the organism.

Citing Articles

Recombinant Vaccine Delivery Vehicle: A Promising Tool to Treat Infections and Combat Antimicrobial Resistance.

Dieye Y, Nguer C, Thiam F, Diouara A, Fall C Antibiotics (Basel). 2022; 11(12).

PMID: 36551358 PMC: 9774608. DOI: 10.3390/antibiotics11121701.


Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation.

Ofori E, Adinortey C, Bockarie A, Kyei F, Tagoe E, Adinortey M Biomed Res Int. 2019; 2019:7312908.

PMID: 31886245 PMC: 6925786. DOI: 10.1155/2019/7312908.


Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys.

Testerman T, Semino-Mora C, Cann J, Qiang B, Pena E, Liu H PLoS One. 2019; 14(9):e0222001.

PMID: 31490998 PMC: 6730863. DOI: 10.1371/journal.pone.0222001.


Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.

Rizwan M, Fatima N, Alvi A Saudi J Gastroenterol. 2014; 20(4):212-8.

PMID: 25038206 PMC: 4131303. DOI: 10.4103/1319-3767.136935.


A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.

Garza-Gonzalez E, Perez-Perez G, Maldonado-Garza H, Bosques-Padilla F World J Gastroenterol. 2014; 20(6):1438-49.

PMID: 24587620 PMC: 3925853. DOI: 10.3748/wjg.v20.i6.1438.


References
1.
Friedman G, SIEGELAUB A, SELTZER C . Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med. 1974; 290(9):469-73. DOI: 10.1056/NEJM197402282900901. View

2.
Wyatt J, Rathbone B, Dixon M, Heatley R . Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol. 1987; 40(8):841-8. PMC: 1141122. DOI: 10.1136/jcp.40.8.841. View

3.
Cover T, Dooley C, Blaser M . Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun. 1990; 58(3):603-10. PMC: 258508. DOI: 10.1128/iai.58.3.603-610.1990. View

4.
Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S . A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int J Cancer. 1990; 45(5):896-901. DOI: 10.1002/ijc.2910450520. View

5.
Crabtree J, Taylor J, Wyatt J, Heatley R, Shallcross T, Tompkins D . Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991; 338(8763):332-5. DOI: 10.1016/0140-6736(91)90477-7. View